DocuSign (NASDAQ:DOCU) Releases Earnings Results, Beats Expectations By $0.02 EPS

DocuSign (NASDAQ:DOCU - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02, Briefing.com reports. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same quarter in the previous year, the company earned $0.76 EPS. The company's quarterly revenue was up 9.0% on a year-over-year basis. DocuSign updated its FY 2026 guidance to EPS and its Q1 2026 guidance to EPS.

DocuSign Stock Up 15.3 %

Shares of DocuSign stock opened at $86.14 on Friday. DocuSign has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The business's fifty day moving average is $88.06 and its two-hundred day moving average is $79.04. The firm has a market cap of $17.40 billion, a PE ratio of 17.77, a P/E/G ratio of 6.94 and a beta of 1.02.

Insider Activity

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the completion of the transaction, the chief financial officer now owns 77,851 shares of the company's stock, valued at approximately $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the transaction, the director now directly owns 7,736 shares in the company, valued at approximately $731,825.60. This represents a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 104,422 shares of company stock valued at $9,665,394 over the last quarter. Company insiders own 1.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on DOCU. Piper Sandler boosted their target price on DocuSign from $60.00 to $90.00 and gave the stock a "neutral" rating in a research report on Friday, December 6th. Jefferies Financial Group boosted their price objective on shares of DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Citigroup reissued a "buy" rating on shares of DocuSign in a research note on Thursday, March 6th. HSBC reissued a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. Finally, Wells Fargo & Company increased their target price on DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a report on Friday, December 6th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $95.64.

Remove Ads

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.